anticancer/hemorrhage

Lyen an sove nan clipboard la

Chwazi kalite sòt

13 rezilta yo

Hemostatic injection needle coated with crosslinked chitosan having catechol group and oxidized catechol group

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national phase under the provisions of 35 U.S.C. .sctn. 371 of International Patent Application No. PCT/KR2016/003451 filed Apr. 4, 2016, which in turn claims priority of Korean Patent Application No. 10-2015-0047329 filed Apr. 3,

Chimeric proteins with phosphatidylserine binding domains

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. BACKGROUND OF THE INVENTION Hemostasis (the process of initiating blood coagulation in order to stop bleeding) may be abnormal and possibly life-threatening under a number of circumstances, yet there is a need for

Combination bacteriolytic therapy for the treatment of tumors

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD OF THE INVENTION This invention is related to the field of oncology. In particular it relates to combined biological and chemical treatments of tumors. BACKGROUND OF THE INVENTION Despite enormous progress in understanding the pathophysiology of neoplasia, advanced forms of cancer

Proteinaceous substance showing antitumorous action and its preparing method

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The substance of the present invention is an antitumor-proteinaceous substance that is released into the culture supernatant by cultured cells such as mammalian cultured cells that are able to proliferate without any restriction and to

Reduced side-effect hemoglobin compositions

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The invention relates to novel hemoglobin compositions, particularly novel recombinant mutant hemoglobin compositions, which eliminate or substantially reduce 1) the creation of heart lesions, 2) gastrointestinal discomfort, 3) pressor effects, and 4) endotoxin

Reduced side-effect hemoglobin compositions

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Apparatus and method for the treatment of esophageal varices and mucosal neoplasms

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION The present invention relates generally to the treatment of esophageal varices, and more particularly to a method and apparatus for applying sclerosant or thrombosant agents to esophageal varices. Further, the present invention relates to a method for the destruction of

Apparatus and method for the treatment of esophageal varices and mucosal neoplasms

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The invention relates to therapeutic polypeptides useful in treating and/or preventing various medical conditions. Examples of therapeutic effects of the therapeutic polypeptides include anti-HIV, anti-cancer, anti-wasting, pro-hematopoietic (e.g., anemias, radiation or

Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

3. FIELD OF THE INVENTION The invention relates to therapeutic polypeptides useful in treating and/or preventing various medical conditions. Examples of therapeutic effects of the therapeutic polypeptides include anti-HIV, anti-cancer, anti-wasting, pro-hematopoietic (e.g., anemias, radiation or

Method for enhancing transport of gases to tissues

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This is application is a nonprovisional of our co-pending U.S. application Ser. No. 60/007,888 filed Dec. 1, 1995, the disclosure of which is incorporated herein by reference. FIELD OF THE INVENTION The present invention relates generally to methods of using various gas carriers to enhance the

Chimeric proteins with phosphatidylserine binding domains

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Pyridine derivative

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD The present invention relates to a pyridine derivative having an ability to act as a neurotrophic factor and a salt thereof. BACKGROUND ART It has been suggested that in Alzheimer's disease, which has recently been increasing in prevalence, degeneration and dysfunction of cholinergic

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye